Trafalgar International (GCAN) Market Capitalization (2018 - 2026)
Trafalgar International (GCAN) posted Market Capitalization of $236233.8 for Q1 2026, up 212.5% on a QoQ basis from $75594.8 in Q4 2025, and down 99.98% year-over-year from $1.0 billion in Q1 2025.
Analysis
Trafalgar International (GCAN) Market Capitalization (2018 - 2026) Analysis & Trends
Trafalgar International has reported Market Capitalization for 9 years, with the latest figure at $236233.8 in Q1 2026.
- On a quarterly basis, Market Capitalization fell 99.98% year-over-year to $236233.8 in Q1 2026; TTM through Mar 2026 was $236233.8, a 99.98% decrease from a year earlier, with the FY2025 full-year figure at $75594.8, down 99.98% from the prior year.
- Market Capitalization was $236233.8 for Q1 2026 at Trafalgar International, up from $75594.8 in the prior quarter.
- The five-year high for Market Capitalization was $2.2 billion in Q1 2022, with the low at $75594.8 in Q4 2025.
- Average Market Capitalization over 5 years is $705.5 million, with a median of $724.2 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Market Capitalization jumped 115.36% in 2023, then sank 99.98% in 2025.
- Over 5 years, Market Capitalization stood at $482.0 million in 2022, then soared by 115.36% to $1.0 billion in 2023, then sank by 53.49% to $482.8 million in 2024, then plunged by 99.98% to $75594.8 in 2025, then soared by 212.5% to $236233.8 in 2026.
- The last three Market Capitalization figures came in at $236233.8 (Q1 2026), $75594.8 (Q4 2025), and $405115.2 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 236,233.75 |
| Dec 31, 2025 | 75,594.80 |
| Sep 30, 2025 | 405,115.19 |
| Jun 30, 2025 | 404.97 Mn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 482.78 Mn |
| Sep 30, 2024 | 603.48 Mn |
| Jun 30, 2024 | 965.57 Mn |
| Mar 31, 2024 | 724.17 Mn |
| Dec 31, 2023 | 1.04 Bn |
| Sep 30, 2023 | 922.37 Mn |
| Jun 30, 2023 | 600.76 Mn |
| Mar 31, 2023 | 769.27 Mn |
| Dec 31, 2022 | 481.98 Mn |
| Sep 30, 2022 | 802.37 Mn |
| Jun 30, 2022 | 960.55 Mn |
| Mar 31, 2022 | 2.21 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Sep 30, 2021 | 3.97 Bn |
| Jun 30, 2021 | 5.67 Bn |